awmsg logo



bupivacaine hydrochloride/fentanyl (Bufyl®)


Reference No. 1578

Publication date:
13/11/2012


Last review date:
30/09/2016

Appraisal information

bupivacaine hydrochloride/fentanyl (Bufyl®) 1 mg/ml/2 micrograms/ml solution for infusion
bupivacaine hydrochloride/fentanyl (Bufyl®) 1.25 mg/ml/2 micrograms/ml solution for infusion


Company: Amdipharm Mercury Company Ltd
BNF category: Anaesthesia
NMG meeting date: 05/09/2012
AWMSG meeting date: 17/10/2012
   
   
Submission Type: Limited Submission
Status: Recommended
Advice No: 3412
Ministerial ratification: 09/11/2012

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Bupivacaine hydrochloride/fentanyl solution for infusion (Bufyl®) is recommended as an option for use within NHS Wales for maintaining analgesia post-operatively and for maintaining epidural analgesia during labour.
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download